Anticoagulants: Clinical Trials

43 trials for Anticoagulants, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 10 unknown, 4 recruiting, 2 not yet recruiting. 20 Not applicable, 10 Phase 4, 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable20Completed 13, Unknown 4, Recruiting 2, Withdrawn 1
Phase 410Completed 5, Recruiting 2, Unknown 2, Terminated 1
Phase 24Completed 1, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 11Completed 1

Follow Anticoagulants: new trials by email Literature Review of Anticoagulants trials Research Report on Anticoagulants

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Changes in the Etiology of Acute Limb Ischemia in the DOAK Era
Acute Limb Ischemia, Anticoagulants
Not yet recruitingUniversity Hospital Augsburg4002026-11-012026-10-22
Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
catheter ablation combined with LAAO (Left Atrial Appendage Occlusion), Atrial Fibrillation Radiofrequency Ablation Only - Atrial Fibrillation (AF), Stroke
Not applicableRecruitingGuangdong Provincial People's Hospital2002026-03-242026-06-08
A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation
Apixaban (Eliquis), Placebo - Venous Malformation, Low Flow, Anticoagulants
Phase 2Not yet recruitingOslo University Hospital202025-02-012024-12-11
Variability in Micro-CT Imaging Results to Quantify Dialyzer Clotting
anticoagulation dosing - Hemodialysis Complication, Anticoagulants
Not applicableCompletedUniversity Hospital, Ghent102024-01-082024-02-22
Application of "I-Anticoagulation"in Patients With Atrial Fibrillation
Use of "I-Anticoagulation" to make the decision and manage patients - Atrial Fibrillation, Anticoagulants
Not applicableUnknownRenJi Hospital4402023-11-152023-11-18
Self-care and Self-efficacy Scale in Oral Anticoagulation Therapy
Self-assess and reporting self-care self-efficacy levels - Anticoagulants, Self Efficacy
UnknownIRCCS Policlinico S. Donato3122023-11-012023-10-05
Dialysis Performance of the FX CorAL Membrane
Anticoagulation dosing, Blood sampling, Duration of the dialysis session - Hemodialysis Complication, Anticoagulants
Not applicableCompletedUniversity Hospital, Ghent102023-10-022025-03-10
Shared Decision for Drug Interactions in Oral Anticoagulation
Shared Decision Making Tool - Anticoagulants, Drug Interactions
Not applicableCompletedUniversity of Utah6102023-10-012026-10-23
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
Double antiplatelet therapy, Aspirin, Brain MRI - Atrial Fibrillation, Atrial Appendage
Phase 4RecruitingUniversity Hospital, Bordeaux602022-10-032026-06-10
Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention
Uninterrupted DOAC use, Interrupted DOAC use - Atrial Fibrillation, Coronary Artery Disease
Not applicableRecruitingZuyderland Medisch Centrum12702022-09-012026-05-29
Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
Enoxaparin Sodium, Bivalirudin - Acute Respiratory Failure, SARS CoV 2 Infection
Not applicableCompletedUniversity Magna Graecia582022-04-202022-08-19
Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation
Oral anticoagulant - Atrial Fibrillation, Obesity
UnknownAjou University School of Medicine562722022-01-012023-07-27
HYDROxychloroquine in Syndrome Primary AntiPhospholipid
Plaquenil 200Mg Tablet, Placebo oral tablet - Antiphospholipid Syndrome in Pregnancy, Anticoagulants
Phase 2WithdrawnAssistance Publique - Hôpitaux de Paris2021-07-092026-04-06
MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings
Academic Detailing (AD), LEAP - Polypharmacy, Insomnia
Not applicableCompletedVA Office of Research and Development242021-05-032025-10-15
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer
Long DOAC, Short DOAC - Venous Thrombosis, Neoplasms
Phase 4CompletedTakeshi Morimoto1792021-02-182025-03-11
Coordination of Oral Anticoagulant Care at Hospital Discharge
Anticoagulation Coordinated Care - Anticoagulants
Not applicableCompletedSt. Joseph's Healthcare Hamilton562020-12-162022-10-26
Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare
Apixaban - Atrial Fibrillation, Obesity
CompletedPfizer1073832020-11-022023-05-22
Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)
Lovenox - Pregnancy, High Risk, Anticoagulants
Phase 4RecruitingUniversity of California, Irvine122020-10-012025-10-29
Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization
Combination drug - Ischemia, Anticoagulants
Phase 1 / Phase 2CompletedMansoura University15362019-07-032022-07-19
Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
Bivalirudin, Unfractionated heparin - Extracorporeal Membrane Oxygenation Complication, Anticoagulants
Phase 4UnknownLegacy Health System342019-05-232019-05-28

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Atrial Fibrillation (13)  ·  Obesity (3)  ·  Stroke (3)  ·  Hemorrhage (2)  ·  Thromboembolism (2)  ·  Venous Thromboembolism (2)  ·  Venous Thrombosis (2)  ·  Acute Kidney Injury (1)  ·  Angina, Stable (1)  ·  Angina, Unstable (1)  ·  Aortic Valve Disease (1)  ·  Behavioral Symptoms (1)  ·  COVID-19 (1)  ·  Coronary Artery Disease (1)  ·  Frailty (1)

Broader conditions

Cardiovascular Diseases (22)  ·  Pathological Conditions, Signs and Symptoms (18)  ·  Pathologic Processes (16)  ·  Heart Diseases (15)  ·  Arrhythmias, Cardiac (13)  ·  Vascular Diseases (13)  ·  Embolism and Thrombosis (8)  ·  Nervous System Diseases (4)  ·  Signs and Symptoms (4)  ·  Body Weight (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cerebrovascular Disorders (3)  ·  Nutrition Disorders (3)  ·  Nutritional and Metabolic Diseases (3)

Interventions

Heparin (3)  ·  apixaban (3)  ·  bivalirudin (3)  ·  Enoxaparin (2)  ·  ATP Binding Cassette Transporter, Subfamily B, Member 1 (1)  ·  Anticoagulants (1)  ·  Aspirin (1)  ·  Blood Specimen Collection (1)  ·  Dabigatran (1)  ·  Drug Combinations (1)  ·  Drug-Eluting Stents (1)  ·  Hydroxychloroquine (1)  ·  Influenza Vaccines (1)  ·  Percutaneous Coronary Intervention (1)  ·  Rivaroxaban (1)

Sponsors

Cui Yimin (2)  ·  IRCCS Policlinico S. Donato (2)  ·  University Hospital, Ghent (2)  ·  University of Utah (2)  ·  VA Office of Research and Development (2)  ·  Ajou University School of Medicine (1)  ·  Arianna Anticoagulazione Foundation (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  CeloNova BioSciences, Inc. (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Centre Hospitalier Universitaire de la Réunion (1)  ·  Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1)  ·  Guangdong Provincial People's Hospital (1)  ·  I.M. Sechenov First Moscow State Medical University (1)

Countries

United States (13)  ·  France (6)  ·  Italy (6)  ·  Belgium (4)  ·  China (3)  ·  Netherlands (3)  ·  Canada (2)  ·  Switzerland (2)  ·  Denmark (1)  ·  Egypt (1)  ·  Finland (1)  ·  Germany (1)  ·  Israel (1)  ·  Japan (1)  ·  Latvia (1)

Top investigators

Wim Van Biesen, PhD (2)  ·  Aaron A Reeves, M.D. (1)  ·  Adnan Kastrati (1)  ·  Afshan Hameed (1)  ·  Alfonso Iorio (1)  ·  Ali McMichael, MD (1)  ·  Alok Kapoor, MD, MSca (1)  ·  Ann M. Borzecki, MD MPH (1)  ·  Anna Falanga, MD (1)  ·  Anna Maria Iorio (1)  ·  Anne Holbrook, MD,PharmD,MSc (1)  ·  Anne Kuitunen, MD, PhD (1)  ·  Ariel Domlyn, PhD (1)

Results publications

PMID 19853687, PMID 20386004, PMID 23033226, PMID 23415013, PMID 24970794, PMID 27349472, PMID 28367699, PMID 29415203, PMID 29504981, PMID 31837559, PMID 32063041, PMID 32178684, PMID 32963065, PMID 33172464, PMID 33224753, PMID 33423512, PMID 33608239, PMID 34333589, PMID 35568903, PMID 35914222, PMID 35918731, PMID 38056770, PMID 38267024, PMID 38692712, PMID 39269742, PMID 39405373, PMID 39556015, PMID 39585174, PMID 40050141, PMID 40529793, PMID 41757461, PMID 42055156, PMID 42307155

NIH funding

2017 (1)